Your browser doesn't support javascript.
loading
Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity.
Dalgaard, Kevin; Landgraf, Kathrin; Heyne, Steffen; Lempradl, Adelheid; Longinotto, John; Gossens, Klaus; Ruf, Marius; Orthofer, Michael; Strogantsev, Ruslan; Selvaraj, Madhan; Lu, Tess Tsai-Hsiu; Casas, Eduard; Teperino, Raffaele; Surani, M Azim; Zvetkova, Ilona; Rimmington, Debra; Tung, Y C Loraine; Lam, Brian; Larder, Rachel; Yeo, Giles S H; O'Rahilly, Stephen; Vavouri, Tanya; Whitelaw, Emma; Penninger, Josef M; Jenuwein, Thomas; Cheung, Ching-Lung; Ferguson-Smith, Anne C; Coll, Anthony P; Körner, Antje; Pospisilik, J Andrew.
Afiliación
  • Dalgaard K; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Landgraf K; Department of Women's and Child Health, Center for Pediatric Research Leipzig, University Hospital for Children & Adolescents, University of Leipzig, 04103 Leipzig, Germany; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, 04103 Leipzig, Germany.
  • Heyne S; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Lempradl A; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Longinotto J; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Gossens K; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Ruf M; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Orthofer M; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences,1030 Vienna, Austria.
  • Strogantsev R; Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
  • Selvaraj M; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Lu TT; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Casas E; Institute for Predictive and Personalized Medicine of Cancer (IMPPC) and Josep Carreras Leukaemia Research Institute, Can Ruti Campus, Ctra de Can Rutí, Cami de les Escoles s/n, Badalona 08916, Barcelona, Spain.
  • Teperino R; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Surani MA; Wellcome Trust Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK; Wellcome Trust-MRC Stem Cell Institute, University of Cambrid
  • Zvetkova I; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Rimmington D; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Tung YC; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Lam B; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Larder R; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Yeo GS; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • O'Rahilly S; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Vavouri T; Institute for Predictive and Personalized Medicine of Cancer (IMPPC) and Josep Carreras Leukaemia Research Institute, Can Ruti Campus, Ctra de Can Rutí, Cami de les Escoles s/n, Badalona 08916, Barcelona, Spain.
  • Whitelaw E; Department of Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Melbourne, VIC 3086, Australia.
  • Penninger JM; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences,1030 Vienna, Austria.
  • Jenuwein T; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
  • Cheung CL; Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, The University of Hong Kong, Hong Kong.
  • Ferguson-Smith AC; Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
  • Coll AP; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Körner A; Department of Women's and Child Health, Center for Pediatric Research Leipzig, University Hospital for Children & Adolescents, University of Leipzig, 04103 Leipzig, Germany; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, 04103 Leipzig, Germany.
  • Pospisilik JA; Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany. Electronic address: pospisilik@ie-freiburg.mpg.de.
Cell ; 164(3): 353-64, 2016 Jan 28.
Article en En | MEDLINE | ID: mdl-26824653
ABSTRACT
More than one-half billion people are obese, and despite progress in genetic research, much of the heritability of obesity remains enigmatic. Here, we identify a Trim28-dependent network capable of triggering obesity in a non-Mendelian, "on/off" manner. Trim28(+/D9) mutant mice exhibit a bi-modal body-weight distribution, with isogenic animals randomly emerging as either normal or obese and few intermediates. We find that the obese-"on" state is characterized by reduced expression of an imprinted gene network including Nnat, Peg3, Cdkn1c, and Plagl1 and that independent targeting of these alleles recapitulates the stochastic bi-stable disease phenotype. Adipose tissue transcriptome analyses in children indicate that humans too cluster into distinct sub-populations, stratifying according to Trim28 expression, transcriptome organization, and obesity-associated imprinted gene dysregulation. These data provide evidence of discrete polyphenism in mouse and man and thus carry important implications for complex trait genetics, evolution, and medicine.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Delgadez / Proteínas Nucleares / Epigénesis Genética / Haploinsuficiencia / Obesidad Tipo de estudio: Prognostic_studies Límite: Adolescent / Animals / Child / Child, preschool / Humans Idioma: En Revista: Cell Año: 2016 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Delgadez / Proteínas Nucleares / Epigénesis Genética / Haploinsuficiencia / Obesidad Tipo de estudio: Prognostic_studies Límite: Adolescent / Animals / Child / Child, preschool / Humans Idioma: En Revista: Cell Año: 2016 Tipo del documento: Article País de afiliación: Alemania